Urologic Oncology: Seminars and Original Investigations
Volume 28, Issue 2 , Pages 189-194, March 2010

Prevention of urinary bladder cancer in the FHIT knock-out mouse with Rofecoxib, a Cox-2 inhibitor

  • Domenico D'Arca, Ph.D.

      Affiliations

    • Department of Urology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA
    • Dipartimento di Scienze Biomediche, Sezione di Chimica Biologica, University of Modena and Reggio Emilia, Modena, Italy
    • These authors contributed equally to this work.
  • ,
  • James LeNoir, Ph.D.

      Affiliations

    • Department of Urology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA
    • These authors contributed equally to this work.
  • ,
  • Bernadette Wildemore, M.D.

      Affiliations

    • Department of Pathology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA
    • These authors contributed equally to this work.
  • ,
  • Fedra Gottardo, M.D.

      Affiliations

    • Department of Urology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA
    • These authors contributed equally to this work.
  • ,
  • Emma Bragantini, M.D.

      Affiliations

    • Department of Urology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA
    • Current address: Department of Pathology, Anatomic Pathology Unit, University of Verona, Verona.
  • ,
  • Dolores Shupp-Byrne, Ph.D.

      Affiliations

    • Department of Urology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA
  • ,
  • Nicola Zanesi, M.D.

      Affiliations

    • Department of Molecular Virology, Immunology, and Medical Genetics, Comprehensive Cancer Center, Ohio State University, Columbus, OH 43210, USA
    • NZ is a Kimmel Scholar.
  • ,
  • Matteo Fassan, M.D.

      Affiliations

    • Department of Urology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA
    • Current address: Department of Diagnostic Sciences and Special Therapies, Pathology Unit, University of Padova, Padova.
  • ,
  • Carlo M. Croce, M.D.

      Affiliations

    • Department of Molecular Virology, Immunology, and Medical Genetics, Comprehensive Cancer Center, Ohio State University, Columbus, OH 43210, USA
  • ,
  • Leonard G. Gomella, M.D.

      Affiliations

    • Department of Urology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA
  • ,
  • Raffaele Baffa, M.D.

      Affiliations

    • Department of Urology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA
    • Current address: Department of Translational Sciences, Research, MedImmune, Gaithersburg, MD.
    • Corresponding Author InformationCorresponding author. Tel.: +1-215-955-9072; fax: +1-215-503-2627

Received 13 June 2008; received in revised form 14 January 2009; accepted 15 January 2009. published online 17 April 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 This work was supported by a Merck and Co., Inc. Medical School grant.

PII: S1078-1439(09)00008-8

doi:10.1016/j.urolonc.2009.01.016

Urologic Oncology: Seminars and Original Investigations
Volume 28, Issue 2 , Pages 189-194, March 2010